GN Hearing CEO: Bose's exit spotlights complexity of hearing aid market
US-based Bose was first to achieve a US approval for a direct-to-consumer hearing aid. Now, as they’re withdrawing from the market, there’ll be one less competitor to worry about, says GN Hearing CEO Gitte Aabo.
by marketwire, translated by daniel pedersen
Yesterday, rumors that audio firm Bose was pulling the plug on its healthcare division, which markets the firm’s hearing aids, were seemingly confirmed by The Boston Globe, citing former and outgoing employees.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
GN Hearing beats analyst expectations for Q1
For subscribers
Analyst: Bose hearing aid exit reflects market complexity
For subscribers
Bose to drop hearing aid business, media reports
For subscribers
